stockrowSunshine Biopharma, Inc. (SBFM) vs China SXT Pharmaceuticals, Inc. (SXTC)
- Sunshine Biopharma, Inc. SBFM 2.71 −2.87%
- China SXT Pharmaceuticals, Inc. SXTC 2.92 −0.34%
Sunshine Biopharma, Inc. and China SXT Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Sunshine Biopharma, Inc. and China SXT Pharmaceuticals, Inc. are of similar size ($2.1M and $2.0M). Sunshine Biopharma, Inc. grew revenue faster over the last twelve months: −2.74% against −54.0%. Sunshine Biopharma, Inc. has the higher net margin (−16.5% vs −255.2%) and the lower return on invested capital (−26.7% vs 0.00%). Across the 17 metrics below, China SXT Pharmaceuticals, Inc. leads on 10 and Sunshine Biopharma, Inc. on 7.
Valuation
| Metric | SBFM | SXTC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| P/E | n/m | n/m | 20.55 |
| P/S | 0.01 | n/m | 2.08 |
| P/B | 0.01 | n/m | 1.79 |
| Price to free cash flow | n/m | n/m | 16.29 |
| EV/EBITDA | 2.40 | 2.66 | 12.22 |
| EV/Sales | (0.33) | (5.94) | 2.87 |
| Earnings yield | (6,843.57%) | (3,722.74%) | (15.94%) |
| Free cash flow yield | (2,844.26%) | 0.00% | 0.00% |
Profitability
| Metric | SBFM | SXTC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 30.30% | 36.69% | 53.51% |
| Operating margin | (16.65%) | 0.00% | 0.00% |
| Net margin | (16.50%) | (255.16%) | (2.45%) |
| Free cash flow margin | (15.66%) | 0.00% | 0.00% |
| Return on equity | (21.93%) | 0.00% | (0.80%) |
| Return on assets | (17.78%) | 0.00% | (1.67%) |
| Return on invested capital | (26.67%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack